UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Contribution of Tobacco Use and 4‑(Methylnitrosamino)-1-(3-pyridyl)-1-butanone to Three Methyl DNA Adducts in Urine

Chemical research in toxicology, 2018-09, Vol.31 (9), p.836-838

2018

Volltextzugriff (PDF)

SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer

International journal of molecular sciences, 2023-08, Vol.24 (15), p.12500

2023

Volltextzugriff (PDF)

Case report: Salivary duct carcinoma in a patient with a germline CDH1 pathogenic variant - expanding the spectrum of hereditary cancer predisposition syndromes

Frontiers in oncology, 2024-04, Vol.14, p.1372382

2024

Volltextzugriff (PDF)

Quantitative profiling of cortisol metabolites in human urine by high-resolution accurate-mass MS

Bioanalysis, 2018-12, Vol.10 (24), p.2015-2026

2018

Volltextzugriff (PDF)

Cytomegalovirus infection in malignant pleural mesothelioma

PloS one, 2021-08, Vol.16 (8), p.e0254136-e0254136

2021

Volltextzugriff (PDF)

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non―Small Cell Lung Cancer

Anesthesia and analgesia, 2011-12, Vol.113 (6), p.1353-1364

2011

Volltextzugriff (PDF)

A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications

PloS one, 2018-05, Vol.13 (5), p.e0197940-e0197940

2018

Volltextzugriff (PDF)

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

Frontiers in immunology, 2023-02, Vol.14, p.1060905-1060905

2023

Volltextzugriff (PDF)

603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A686-A686

2023

Volltextzugriff (PDF)

Bringing attention to e-cigarette pH as an important element for research and regulation

Tobacco control, 2015-07, Vol.24 (4), p.413-414

2015

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors in ROS1-Rearranged Non–Small Cell Lung Cancer: A Report of Two Cases

Journal of thoracic oncology, 2019-08, Vol.14 (8), p.e165-e167

2019

Volltextzugriff (PDF)

Bringing attention to e-cigarette pH as an important element for research and regulation: Table 1

Tobacco control, 2015-07, Vol.24 (4), p.413-414

2015

Volltextzugriff (PDF)

Research on cruciferous vegetables, indole-3-carbinol, and cancer prevention: A tribute to Lee W. Wattenberg

Molecular nutrition & food research, 2016-06, Vol.60 (6), p.1228-1238

2016

Volltextzugriff (PDF)

Abstract 3333: Potential of kava in reducing lung cancer risk, tobacco use, and associated disparities

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3333-3333

2019

Volltextzugriff (PDF)

Final results of a phase 1 trial of sorafenib, pemetrexed, and cisplatin in patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e14582-e14582

2018

Volltextzugriff (PDF)

Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis

Carcinogenesis (New York), 2022-08, Vol.43 (7), p.659-670

2022

Volltextzugriff (PDF)

Animated patient’s guide to lung cancer enables shared decisions and improves health outcomes

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18634-e18634

2021

Volltextzugriff (PDF)

Detection and quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) from smoker albumin and its potential as a surrogate biomarker of tobacco-specific nitrosamines exposure and bioactivation

Toxicology letters, 2019-09, Vol.311, p.11-16

2019

Volltextzugriff (PDF)

One-Week Kava Dietary Supplementation Increases Both Urinary N- and O‑Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers

Chemical research in toxicology, 2024-09, Vol.37 (9), p.1515-1523

2024

Volltextzugriff (PDF)

BTCRC-HN17-111, A phase 2 trial of ADT (goserelin) in combination with pembrolizumab for patients with advanced salivary gland tumors expressing androgen receptor (AR)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18091-e18091

2022

Volltextzugriff (PDF)

Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study

Lung cancer (Amsterdam, Netherlands), 2024-09, Vol.195, p.107932, Article 107932

2024

Volltextzugriff (PDF)

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

Cancers, 2020-09, Vol.12 (9), p.2659

2020

Volltextzugriff (PDF)

A phase I trial of plinabulin in combination with nivolumab and ipilimumab in patients with relapsed small cell lung cancer (SCLC): Big Ten Cancer Research Consortium (BTCRC-LUN17-127) study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.8570-8570

2021

Volltextzugriff (PDF)

Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade

Cancer Immunology, Immunotherapy, 2023-05, Vol.72 (5), p.1225-1232

2023

Volltextzugriff (PDF)

Consolidation nivolumab plus ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: BTCRC LUN 16-081

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.8509-8509

2022

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(142)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Contribution of Tobacco Use and 4‑(Methylnitrosamino)-1-(3-pyridyl)-1-butanone to Three Methyl DNA Adducts in Urine

SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer

Case report: Salivary duct carcinoma in a patient with a germline CDH1 pathogenic variant - expanding the spectrum of hereditary cancer predisposition syndromes

Quantitative profiling of cortisol metabolites in human urine by high-resolution accurate-mass MS

Cytomegalovirus infection in malignant pleural mesothelioma

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non―Small Cell Lung Cancer

A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer

603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study

Bringing attention to e-cigarette pH as an important element for research and regulation

Immune Checkpoint Inhibitors in ROS1-Rearranged Non–Small Cell Lung Cancer: A Report of Two Cases

Bringing attention to e-cigarette pH as an important element for research and regulation: Table 1

Research on cruciferous vegetables, indole-3-carbinol, and cancer prevention: A tribute to Lee W. Wattenberg

Abstract 3333: Potential of kava in reducing lung cancer risk, tobacco use, and associated disparities

Final results of a phase 1 trial of sorafenib, pemetrexed, and cisplatin in patients with advanced solid tumors

Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis

Animated patient’s guide to lung cancer enables shared decisions and improves health outcomes

Detection and quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) from smoker albumin and its potential as a surrogate biomarker of tobacco-specific nitrosamines exposure and bioactivation

One-Week Kava Dietary Supplementation Increases Both Urinary N- and O‑Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers

BTCRC-HN17-111, A phase 2 trial of ADT (goserelin) in combination with pembrolizumab for patients with advanced salivary gland tumors expressing androgen receptor (AR)

Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

A phase I trial of plinabulin in combination with nivolumab and ipilimumab in patients with relapsed small cell lung cancer (SCLC): Big Ten Cancer Research Consortium (BTCRC-LUN17-127) study

Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade

Consolidation nivolumab plus ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: BTCRC LUN 16-081

Suchergebnisse filtern